Phosphorylation of RAB7 by TBK1/IKKε Regulates Innate Immune Signaling in Triple-Negative Breast Cancer
Jessica L Ritter1, Zehua Zhu2, Tran C Thai2
1Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA.
Abstract:
Triple-negative breast cancer (TNBC) is a heterogeneous disease enriched for mutations in PTEN and dysregulation of innate immune signaling. Here, we demonstrate that Rab7, a recently identified substrate of PTEN phosphatase activity, is also a substrate of the innate immune signaling kinases TANK-binding kinase 1 (TBK1)/IκB kinase ε (IKKε) on the same serine-72 (S72) site. An unbiased search for novel TBK1/IKKε substrates using stable isotope labeling with amino acids in cell culture phosphoproteomic analysis identified Rab7-S72 as a top hit. PTEN-null TNBC cells expressing a phosphomimetic version of Rab7-S72 exhibited diffuse cytosolic Rab7 localization and enhanced innate immune signaling, in contrast to a kinase-resistant version, which localized to active puncta that promote lysosomal-mediated stimulator of interferon genes (STING) degradation. Thus, convergence of PTEN loss and TBK1/IKKε activation on Rab7-S72 phosphorylation limited STING turnover and increased downstream production of IRF3 targets including CXCL10, CCL5, and IFNβ. Consistent with this data, PTEN-null TNBC tumors expressed higher levels of STING, and PTEN-null TNBC cell lines were hyperresponsive to STING agonists. Together, these findings begin to uncover how innate immune signaling is dysregulated downstream of TBK1/IKKε in a subset of TNBCs and reveals previously unrecognized cross-talk with STING recycling that may have implications for STING agonism in the clinic. SIGNIFICANCE: These findings identify Rab7 as a substrate for TBK1 for regulation of innate immune signaling, thereby providing important insight for strategies aimed at manipulating the immune response to enhance therapeutic efficacy in TNBC.
Insights
Triple-negative breast cancer (TNBC) involves PTEN mutations and immune signaling issues. New findings show Rab7 phosphorylation by TBK1/IKKε limits STING degradation, enhancing immune responses in PTEN-null TNBC.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Triple-negative breast cancer (TNBC) is characterized by PTEN mutations and innate immune signaling dysregulation.
- Rab7 is a known substrate of PTEN phosphatase activity.
- Innate immune signaling kinases TBK1/IKKε are implicated in TNBC pathogenesis.
Purpose of the Study:
- To investigate the role of Rab7 as a substrate for TBK1/IKKε in TNBC.
- To elucidate the mechanism by which PTEN loss and TBK1/IKKε activation converge on Rab7.
- To explore the implications of Rab7 phosphorylation for STING regulation and innate immune signaling in TNBC.
Main Methods:
- Phosphoproteomic analysis using stable isotope labeling with amino acids in cell culture to identify novel TBK1/IKKε substrates.
- Expression of phosphomimetic and kinase-resistant Rab7 mutants in PTEN-null TNBC cells.
- Assessment of Rab7 localization, STING degradation, and innate immune signaling activation (e.g., IRF3 targets).
- Analysis of STING expression in PTEN-null TNBC tumors and cell lines.
Main Results:
- Rab7 was identified as a novel substrate for TBK1/IKKε at serine-72 (S72).
- Phosphorylation of Rab7-S72 by TBK1/IKKε in PTEN-null TNBC cells led to diffuse cytosolic localization and enhanced innate immune signaling.
- This phosphorylation event limited lysosomal-mediated STING degradation, increasing downstream IRF3 target gene production (CXCL10, CCL5, IFNβ).
- PTEN-null TNBC tumors and cell lines exhibited higher STING levels and hyperresponsiveness to STING agonists.
Conclusions:
- Rab7 acts as a key convergence point for PTEN loss and TBK1/IKKε activation in TNBC.
- Rab7 phosphorylation by TBK1/IKKε regulates STING turnover, impacting innate immune signaling.
- These findings reveal a novel cross-talk mechanism with STING recycling and suggest potential therapeutic strategies targeting STING agonism in TNBC.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Receptor Tyrosine Kinases


